Co-expression of multiple transcription factors is associated with clinical features and endocrine prognosis in growth hormone-secreting pituitary adenomas
Endocrine · 25.10.2024 · 87 (2) · 788-799
DOI: 10.1007/s12020-024-04082-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine, online erschienen am 25.10.2024. Verfasst von Yu Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, PR China. Hauptthemen laut MEDLINE: Adenoma, Growth Hormone-Secreting Pituitary Adenoma, Transcription Factors, Pituitary Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: the Capital clinical characteristic diagnosis and treatment technology research and translational application topic, the Public Welfare Development and Reform Pilot Project of Beijing Medical Research Institute.
Abstract (Originalsprache)
BACKGROUND: The types of growth hormone-secreting pituitary adenomas are diverse, we have found that there are significant differences in clinical features and prognosis between PIT-1 single-cell spectrum growth hormone adenomas and growth hormone phenotypic polyhormonal adenomas. METHODS: This study examined a cohort of 193 patients with growth hormone-secreting pituitary adenoma (GHPA), stratifying them into two groups: PIT-1 single transcription factor positive growth hormone adenoma (STF-GHPA) and Multiple transcription factor-positive growth hormone-secreting adenomas (MTF-GHPA). The objective was to compare these two groups' clinical characteristics. Within the MTF-GHPA group, we further subtyped them based on transcription factors to evaluate potential variations in clinical manifestations. Logistic regression analyses were employed to develop a risk factor model for investigating factors influencing hormone remission. RESULTS: There were no statistically significant differences in terms of age, gender, serum GH, and IGF-1 levels between patients diagnosed with MTF-GHPA and STF-GHPA. However, patients with MTF-GHPA exhibited a higher proportion of hypopituitarism compared to those with STF-GHPA. Furthermore, MTF-GHPA were characterized by smaller tumor size and less invasiveness, as indicated by lower Knosp classes. However, patients with MTF-GHPA have a lower rate of hormonal remission (30.8%) and more postoperative complications (31.0%), which means that STF-GHPA (hormonal remission:71.6%; postoperative complications:13.4%) has a better endocrine outcome than MTF-GHPA patients. Between the PIT-1 + SF-1+ and PIT-1 + TPIT+ subtypes within MTF-GHPA, significant differences were also observed in tumor size, endocrine outcomes, and postoperative complications. Risk factors influencing hormonal remission for GHPA included preoperative GH level, primary/recurrent, extent of resection, and transcription factor expression. CONCLUSION: Co-expression of multiple transcription factors is an important factor associated with clinical behavior and endocrine outcomes in patients with GHPA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, PR China.
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, PR China. pinanliu@ccmu.edu.cn.
- Department of Neural Reconstruction, Beijing Key Laboratory of Central Nervous System Injury, Beijing Neurosurgical Institute, Capital Medical University, Beijing, PR China. pinanliu@ccmu.edu.cn.
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, PR China. zhijunyang@ccmu.edu.cn.
ORCID-Profile: Pinan Liu, Zhijun Yang
Förderung
- the Capital clinical characteristic diagnosis and treatment technology research and translational application topic
- the Public Welfare Development and Reform Pilot Project of Beijing Medical Research Institute
Zitieren
APA
Zhang, Y., Tang, H., Li, S., Bie, Z., Ma, X., Wu, H., Liu, G., Wang, X., Liu, P., & Yang, Z. (2024). Co-expression of multiple transcription factors is associated with clinical features and endocrine prognosis in growth hormone-secreting pituitary adenomas. Endocrine, 87(2), 788-799. https://doi.org/10.1007/s12020-024-04082-x
Vancouver
Zhang Y, Tang H, Li S, Bie Z, Ma X, Wu H, et al. Co-expression of multiple transcription factors is associated with clinical features and endocrine prognosis in growth hormone-secreting pituitary adenomas. Endocrine. 2024;87(2):788-799. doi:10.1007/s12020-024-04082-x
BibTeX
@article{Zhang2024,
author = {Zhang, Yu and Tang, Hanlu and Li, Shiwei and Bie, Zhixu and Ma, Xin and Wu, Hongyu and Liu, Gemingtian and Wang, Xingchao and Liu, Pinan and Yang, Zhijun},
title = {Co-expression of multiple transcription factors is associated with clinical features and endocrine prognosis in growth hormone-secreting pituitary adenomas},
journal = {Endocrine},
year = {2024},
volume = {87},
number = {2},
pages = {788--799},
doi = {10.1007/s12020-024-04082-x}
}
EUVIMED